Osaic Holdings’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.85K | Sell |
150
-617
| -80% | -$7.59K | ﹤0.01% | 6509 |
|
|
2025
Q1 | $7.24K | Sell |
767
-230
| -23% | -$2.17K | ﹤0.01% | 5892 |
|
|
2024
Q4 | $12.3K | Buy |
997
+786
| +373% | +$9.68K | ﹤0.01% | 5597 |
|
|
2024
Q3 | $3.15K | Hold |
211
| – | – | ﹤0.01% | 6270 |
|
|
2024
Q2 | $2.85K | Sell |
211
-65
| -24% | -$878 | ﹤0.01% | 6312 |
|
|
2024
Q1 | $4.59K | Buy |
276
+126
| +84% | +$2.09K | ﹤0.01% | 6016 |
|
|
2023
Q4 | $2.02K | Sell |
150
-3,485
| -96% | -$47K | ﹤0.01% | 6414 |
|
|
2023
Q3 | $39.8K | Buy |
3,635
+150
| +4% | +$1.64K | ﹤0.01% | 5142 |
|
|
2023
Q2 | $45K | Sell |
3,485
-300
| -8% | -$3.88K | ﹤0.01% | 5000 |
|
|
2023
Q1 | $45.4K | Sell |
3,785
-36
| -0.9% | -$432 | ﹤0.01% | 5011 |
|
|
2022
Q4 | $52.6K | Buy |
3,821
+3,321
| +664% | +$45.7K | ﹤0.01% | 4890 |
|
|
2022
Q3 | $7K | Hold |
500
| – | – | ﹤0.01% | 6141 |
|
|
2022
Q2 | $8K | Sell |
500
-2,294
| -82% | -$36.7K | ﹤0.01% | 6196 |
|
|
2022
Q1 | $50K | Buy |
2,794
+1,326
| +90% | +$23.7K | ﹤0.01% | 5077 |
|
|
2021
Q4 | $35K | Sell |
1,468
-182
| -11% | -$4.34K | ﹤0.01% | 5394 |
|
|
2021
Q3 | $50K | Sell |
1,650
-10
| -0.6% | -$303 | ﹤0.01% | 5094 |
|
|
2021
Q2 | $53K | Buy |
1,660
+10
| +0.6% | +$319 | ﹤0.01% | 4992 |
|
|
2021
Q1 | $50K | Buy |
1,650
+508
| +44% | +$15.4K | ﹤0.01% | 4868 |
|
|
2020
Q4 | $37K | Sell |
1,142
-67
| -6% | -$2.17K | ﹤0.01% | 4741 |
|
|
2020
Q3 | $34K | Sell |
1,209
-239
| -17% | -$6.72K | ﹤0.01% | 4560 |
|
|
2020
Q2 | $40K | Buy |
1,448
+59
| +4% | +$1.63K | ﹤0.01% | 4329 |
|
|
2020
Q1 | $28K | Buy |
+1,389
| New | +$28K | ﹤0.01% | 4382 |
|